A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan

Journal of Infection and Chemotherapy

Volumn 23, Issue 6, 2017, Pages 390-393

  Suzuki, Hiroyuki ^a   Hase, Ryota ^b   Otsuka, Yoshihito ^a   Hosokawa, Naoto ^a  

^a KAMEDA MEDICAL CENTER   (Japan)

^b NARITA RED CROSS HOSPITAL   (Japan)

Author keywords

Bacteremia; Enterococcus faecalis; Enterococcus faecium

Indexed keywords

AMPICILLIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BLOODSTREAM INFECTION; CHARLSON COMORBIDITY INDEX; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FEMALE; GYNECOLOGIC INFECTION; HUMAN; JAPAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SOFT TISSUE INFECTION; TERTIARY CARE CENTER; TREATMENT DURATION; VERY ELDERLY; BACTEREMIA; DRUG EFFECTS; ENTEROCOCCUS FAECALIS; GRAM POSITIVE INFECTION; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS;

EID: 85017331325     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2017.03.009     Document Type: Article

References (17)

1. [1] Noskin, G.A., Peterson, L.R., Warren, J.R., Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 20 (1995), 296–301.
2. [2] Garbutt, J.M., Ventrapragada, M., Littenberg, B., Mundy, L.M., Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 30 (2000), 466–472.
3. [3] DiazGranados, C.A., Zimmer, S.M., Klein, M., Jernigan, J.A., Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41 (2005), 327–333.
4. [4] Peel, T., Cheng, A.C., Spelman, T., Huysmans, M., Spelman, D., Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect 18 (2012), 388–394.
5. [5] Billington, E.O., Phang, S.H., Gregson, D.B., Pitout, J.D., Ross, T., Church, D.L., et al. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study. Int J Infect Dis 26 (2014), 76–82.
6. [6] Pinholt, M., Ostergaard, C., Arpi, M., Bruun, N.E., Schonheyder, H.C., Gradel, K.O., et al. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study. Clin Microbiol Infect 20 (2014), 145–151.
7. [7] Caballero-Granado, F.J., Becerril, B., Cuberos, L., Bernabeu, M., Cisneros, J.M., Pachon, J., Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia. Clin Infect Dis 32 (2001), 587–594.
8. [8] Hamada, Y., Magarifuchi, H., Oho, M., Kusaba, K., Nagasawa, Z., Fukuoka, M., et al. Clinical features of enterococcal bacteremia due to ampicillin-susceptible and ampicillin-resistant enterococci: an eight-year retrospective comparison study. J Infect Chemother 21 (2015), 527–530.
9. [9] Kajihara, T., Nakamura, S., Iwanaga, N., Oshima, K., Takazono, T., Miyazaki, T., et al. Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study. BMC Infect Dis, 15, 2015, 426.
10. [10] Wayne, P.A., Reference method for broth dilution antimicrobial susceptibility testing; twenty-fourth informational supplement. CLSI document, 2014, Clinical and Laboratory Standards Institute M100-S24.
11. [11] Kanda, Y., Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 48 (2013), 452–458.
12. [12] Cho, S.Y., Lee, D.G., Choi, S.M., Kwon, J.C., Kim, S.H., Choi, J.K., et al. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study. BMC Infect Dis, 13, 2013, 504.
13. [13] Coque, T.M., Willems, R.J., Fortun, J., Top, J., Diz, S., Loza, E., et al. Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance?. Antimicrob Agents Chemother 49 (2005), 2693–2700.
14. [14] Vincent, S., Knight, R.G., Green, M., Sahm, D.F., Shlaes, D.M., Vancomycin susceptibility and identification of motile enterococci. J Clin Microbiol 29 (1991), 2335–2337.
15. [15] Hidron, A.I., Edwards, J.R., Patel, J., Horan, T.C., Sievert, D.M., Pollock, D.A., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29 (2008), 996–1011.
16. [16] Suppli, M., Aabenhus, R., Harboe, Z.B., Andersen, L.P., Tvede, M., Jensen, J.U., Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy. Clin Microbiol Infect 17 (2011), 1078–1083.
17. [17] Foo, H., Chater, M., Maley, M., van Hal, S.J., Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteremia. J Antimicrob Chemother 69 (2014), 2252–2257.